Single-cell RNA sequencing reveals that VIM and IFITM3 are vital targets of Dengzhan Shengmai capsule to protect against cerebral ischemic injury.
J Ethnopharmacol
; 311: 116439, 2023 Jul 15.
Article
in En
| MEDLINE
| ID: mdl-37004745
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Brain Injuries
/
Reperfusion Injury
/
Brain Ischemia
/
Neuroprotective Agents
/
Stroke
/
Ischemic Stroke
Type of study:
Prognostic_studies
Language:
En
Journal:
J Ethnopharmacol
Year:
2023
Type:
Article